<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">rpcardio</journal-id><journal-title-group><journal-title xml:lang="en">Rational Pharmacotherapy in Cardiology</journal-title><trans-title-group xml:lang="ru"><trans-title>Рациональная Фармакотерапия в Кардиологии</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1819-6446</issn><issn pub-type="epub">2225-3653</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.20996/1819-6446-2016-12-1-63-65</article-id><article-id custom-type="elpub" pub-id-type="custom">rpcardio-1202</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PAGES OF RUSSIAN NATIONAL SOCIETY OF EVIDENCE-BASED PHARMACOTHERAPY</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>СТРАНИЦЫ НАЦИОНАЛЬНОГО ОБЩЕСТВА ДОКАЗАТЕЛЬНОЙ ФАРМАКОТЕРАПИИ</subject></subj-group></article-categories><title-group><article-title>The Moriscos-Green scale: the pros and cons of universal test, correction of mistakes</article-title><trans-title-group xml:lang="ru"><trans-title>ШКАЛА МОРИСКИ-ГРИНА: ПЛЮСЫ И МИНУСЫ УНИВЕРСАЛЬНОГО ТЕСТА, РАБОТА НАД ОШИБКАМИ</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лукина</surname><given-names>Ю. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Lukina</surname><given-names>Yu. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н., с.н.с. лаборатории фармакоэпидемиологических исследований отдела профилактической фармакотерапии ГНИЦПМ</p></bio><email xlink:type="simple">yuvlu@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Марцевич</surname><given-names>С. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Martsevich</surname><given-names>S. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., профессор, руководитель отдела профилактической фармакотерапии ГНИЦПМ</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кутишенко</surname><given-names>Н. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Kutishenko</surname><given-names>N. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., руководитель лаборатории фармакоэпидемиологических исследований того же отдела</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Государственный научно-исследовательский центр профилактической медицины 101990, Москва, Петроверигский пер., 10</institution><country>Россия</country></aff><aff xml:lang="en"><institution>State Research Centre for Preventive Medicine. Petroverigsky per. 10, Moscow, 101990 Russia</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2016</year></pub-date><pub-date pub-type="epub"><day>09</day><month>03</month><year>2016</year></pub-date><volume>12</volume><issue>1</issue><fpage>63</fpage><lpage>65</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Lukina Y.V., Martsevich S.Y., Kutishenko N.P., 2016</copyright-statement><copyright-year>2016</copyright-year><copyright-holder xml:lang="ru">Лукина Ю.В., Марцевич С.Ю., Кутишенко Н.П.</copyright-holder><copyright-holder xml:lang="en">Lukina Y.V., Martsevich S.Y., Kutishenko N.P.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.rpcardio.online/jour/article/view/1202">https://www.rpcardio.online/jour/article/view/1202</self-uri><abstract><p>One of the most common tests for evaluating of medication adherence – 4-question scale Moriscos-Green – is considered. Advantages (flexibility, conciseness) and disadvantages (insufficient sensitivity and specificity) of this test are presented. Disadvantages of 4-question version of the test were considered by the authors in development a new version of the scale (8-question) to assess medication adherence. The latest version of the Moriscos test has a high sensitivity in a fairly good specificity. The versatility of the new version of the test is confirmed by the studies. Preference in the use of this test is shown for screening assessment of medication adherence in patients with various chronic diseases. Besides the use of 8-question Moriscos scale is proved as a reference in the development and validation of new questionnaires on adherence to therapy.</p></abstract><trans-abstract xml:lang="ru"><p>Рассматривается один из наиболее распространенных тестов для оценки приверженности лечению – 4-вопросная шкала Мориски-Грина. Оцениваются достоинства (универсальность, лаконичность) и недостатки (недостаточно высокие чувствительность и специфичность) данного теста. Недочеты 4-вопросной версии теста были учтены авторами при разработке новой – 8-вопросной версии шкалы по оценке приверженности терапии. Последний вариант теста Мориски отличается высокой чувствительностью при достаточно хорошей специфичности. Универсальность новой версии теста подтверждена исследованиями. Показана предпочтительность использования данного теста для скрининг-оценки приверженности лечению у пациентов с различными хроническими заболеваниями, а также использования 8-вопросной шкалы Мориски в качестве эталона при разработке и валидизации новых опросников по приверженности терапии.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>приверженность лечению</kwd><kwd>шкала Мориски-Грина</kwd><kwd>опросник</kwd></kwd-group><kwd-group xml:lang="en"><kwd>medication adherence</kwd><kwd>Moriscos-Green scale</kwd><kwd>questionnaire.</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Martsevich, SY, Navasardyan AR Kutishenko NP et al. Experience the study of atrial fibrillation based on the register PROFILE. Kardiovaskulyarnaya Terapiya i Profilaktika 2014; 13 (2): 35-9. In Russian (Марцевич, С.Ю., Навасардян А.Р., Кутишенко Н.П. и соавт. Опыт изучения фибрилляции предсердий на базе регистра ПРОФИЛЬ. Кардиоваскулярная Терапия и Профилактика 2014; 13(2): 35-9).</mixed-citation><mixed-citation xml:lang="en">Martsevich, SY, Navasardyan AR Kutishenko NP et al. Experience the study of atrial fibrillation based on the register PROFILE. Kardiovaskulyarnaya Terapiya i Profilaktika 2014; 13 (2): 35-9. In Russian (Марцевич, С.Ю., Навасардян А.Р., Кутишенко Н.П. и соавт. Опыт изучения фибрилляции предсердий на базе регистра ПРОФИЛЬ. Кардиоваскулярная Терапия и Профилактика 2014; 13(2): 35-9).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Martsevich, SY, Navasardyan AR, Kutishenko NP, Zakharova AV. Assessment of adherence to the admission of new oral anticoagulants (PLA) in patients with atrial fibrillation (AF) according to the register PROFILE. Ration Pharmacother Cardiol 2014; 10 (6): 625-30. In Russian (Марцевич, С.Ю., Навасардян А.Р., Кутишенко Н.П., Захарова А.В. Оценка приверженности к приему новых оральных антикоагулянтов (НОАК) у пациентов с фибрилляцией предсердий (ФП) по данным регистра ПРОФИЛЬ. Рациональная Фармакотерапия в Кардиологии 2014; 10(6): 625-30).</mixed-citation><mixed-citation xml:lang="en">Martsevich, SY, Navasardyan AR, Kutishenko NP, Zakharova AV. Assessment of adherence to the admission of new oral anticoagulants (PLA) in patients with atrial fibrillation (AF) according to the register PROFILE. Ration Pharmacother Cardiol 2014; 10 (6): 625-30. In Russian (Марцевич, С.Ю., Навасардян А.Р., Кутишенко Н.П., Захарова А.В. Оценка приверженности к приему новых оральных антикоагулянтов (НОАК) у пациентов с фибрилляцией предсердий (ФП) по данным регистра ПРОФИЛЬ. Рациональная Фармакотерапия в Кардиологии 2014; 10(6): 625-30).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Morisky D. E., Green L. W., Levine D. M. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986; 24(1): 67-74.</mixed-citation><mixed-citation xml:lang="en">Morisky D. E., Green L. W., Levine D. M. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986; 24(1): 67-74.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Kalashnikova MF, Bondarev IB, Lihodey NV. Adherence to treatment with type 2 diabetes: the definition, the modern methods of assessing patient treatment. Lechashchiy Vrach 2015; 3: 27-33. In Russian (Калашникова М.Ф., Бондарева И.Б., Лиходей Н.В. Приверженность лечению при сахарном диабете 2-го типа: определение понятия, современные методы оценки пациентами проводимого лечения. Лечащий Врач 2015; 3: 27-33).</mixed-citation><mixed-citation xml:lang="en">Kalashnikova MF, Bondarev IB, Lihodey NV. Adherence to treatment with type 2 diabetes: the definition, the modern methods of assessing patient treatment. Lechashchiy Vrach 2015; 3: 27-33. In Russian (Калашникова М.Ф., Бондарева И.Б., Лиходей Н.В. Приверженность лечению при сахарном диабете 2-го типа: определение понятия, современные методы оценки пациентами проводимого лечения. Лечащий Врач 2015; 3: 27-33).</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Lukina YuV, Ginzburg ML, Smirnov VP et al. Adherence to treatment, prior hospitalization for patients with acute coronary syndrome. Klinitsist 2012; 2: 45-53. In Russian (Лукина Ю.В., Гинзбург М.Л., Смирнов В.П. и др. Приверженность лечению, предшествующему госпитализации, у пациентов с острым коронарным синдромом. Клиницист 2012; 2: 45-53).</mixed-citation><mixed-citation xml:lang="en">Lukina YuV, Ginzburg ML, Smirnov VP et al. Adherence to treatment, prior hospitalization for patients with acute coronary syndrome. Klinitsist 2012; 2: 45-53. In Russian (Лукина Ю.В., Гинзбург М.Л., Смирнов В.П. и др. Приверженность лечению, предшествующему госпитализации, у пациентов с острым коронарным синдромом. Клиницист 2012; 2: 45-53).</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Pineiro F., Gil V., Donis M., Orozco D. et al. The validity of 6 indirect methods for assessing drug treatment compliance in arterial hypertension. Aten Primaria 1997; 19 (7): 372-4.</mixed-citation><mixed-citation xml:lang="en">Pineiro F., Gil V., Donis M., Orozco D. et al. The validity of 6 indirect methods for assessing drug treatment compliance in arterial hypertension. Aten Primaria 1997; 19 (7): 372-4.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Morisky DE, Ang A, Krousel-Wood M, Harry J. Ward. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich) 2008; 10(5): 348-54.</mixed-citation><mixed-citation xml:lang="en">Morisky DE, Ang A, Krousel-Wood M, Harry J. Ward. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich) 2008; 10(5): 348-54.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Cuevas C., Peñate W. Psychometric properties of the eight-item Morisky Medication Adherence Scale (MMAS-8) in a psychiatric outpatient setting. International Journal of Clinical and Health Psychology 2015; 18(2): 121-9.</mixed-citation><mixed-citation xml:lang="en">Cuevas C., Peñate W. Psychometric properties of the eight-item Morisky Medication Adherence Scale (MMAS-8) in a psychiatric outpatient setting. International Journal of Clinical and Health Psychology 2015; 18(2): 121-9.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Wang Y., Kong M.C., Ko Y. Psychometric properties of the 8-item Morisky Medication Adherence Scale in patients taking warfarin. Thrombosis and Haemostais 2012;108: 789-95.</mixed-citation><mixed-citation xml:lang="en">Wang Y., Kong M.C., Ko Y. Psychometric properties of the 8-item Morisky Medication Adherence Scale in patients taking warfarin. Thrombosis and Haemostais 2012;108: 789-95.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Yan J., You L.-M., Yang Q., et al. Morisky. Translation and validation of a Chinese version of the 8-</mixed-citation><mixed-citation xml:lang="en">Yan J., You L.-M., Yang Q., et al. Morisky. Translation and validation of a Chinese version of the 8-</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">item Morisky medication adherence scale in myocardial infarction patients. Journal of Evaluation in</mixed-citation><mixed-citation xml:lang="en">item Morisky medication adherence scale in myocardial infarction patients. Journal of Evaluation in</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Clinical Practice 2014, 20: 311-7.</mixed-citation><mixed-citation xml:lang="en">Clinical Practice 2014, 20: 311-7.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Sakthong P., Chabunthom R., Charoevisuthiwongs R. Psychometric properties of the Thai version of the 8-item Morisky Medication Adherence Scale in patients with type 2 diabetes. Annals of Pharmacotherapy 2009; 43: 950-7.</mixed-citation><mixed-citation xml:lang="en">Sakthong P., Chabunthom R., Charoevisuthiwongs R. Psychometric properties of the Thai version of the 8-item Morisky Medication Adherence Scale in patients with type 2 diabetes. Annals of Pharmacotherapy 2009; 43: 950-7.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
